SCHEMBL276231

SCHEMBL276231

CNN(C)C(=O)c1ccc(C(=O)NN)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.46
KDM4E B2RXH2 5/20 0.46
MAPT P10636 4/20 0.46
POLB P06746 3/20 0.46
GAA P10253 5/20 0.38
NPC1 O15118 3/20 0.38
HPGD P15428 3/20 0.38
RAB9A P51151 2/20 0.38
MAPK1 P28482 1/20 0.38
HDAC4 P56524 3/20 0.36
HDAC1 Q13547 3/20 0.36
HDAC6 Q9UBN7 3/20 0.36
HDAC3 O15379 2/20 0.36
TAS1R3 Q7RTX0 1/20 0.36
TAS1R1 Q7RTX1 1/20 0.36
LMNA P02545 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
GLA P06280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1587371 0.84 ALDH1A1 (0.50) ALDH1A1KDM4EMAPTPOLBGAA
SCHEMBL276955 0.80 ALDH1A1 (0.58) ALDH1A1KDM4EMAPTPOLBGAA
SCHEMBL1587423 0.78 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTPOLBGAA
SCHEMBL276180 0.78 NPSR1 (0.49) ALDH1A1KDM4EMAPTGAANPC1
SCHEMBL1588053 0.78 ALDH1A1 (0.51) ALDH1A1KDM4EMAPTPOLBGAA
SCHEMBL12265915 0.77 ALDH1A1 (0.50) ALDH1A1KDM4EMAPTPOLBGAA
SCHEMBL19316038 0.74 HDAC6 (0.56) ALDH1A1KDM4EMAPTPOLBGAA
SCHEMBL7599933 0.74 MPO (0.52) ALDH1A1KDM4EMAPTMAPK1HDAC1
SCHEMBL6361893 0.74 ALDH1A1 (0.50) ALDH1A1KDM4EMAPTPOLBGAA
SCHEMBL14145228 0.72 F2 (0.54) ALDH1A1KDM4EMAPTPOLBGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8134013-B2 Amide compound and thrombopoietin receptor activator NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2012-03-13 US disclosed
US-20090131659-A1 AMIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2009-05-21 US disclosed
EP-1845090-A1 AMIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR Nissan Chemical Industries, Ltd. (JP) 2007-10-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131659-A1 AMIDE COMPOUND AND THROMBOPOIETIN RECEPTOR ACTIVATOR TEK, PTAFR, MPL ALDH1A1 2047/4885KDM4E 4435/4885MAPT 311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.